August 20, 2016Open Access
View Full PaperThe economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe
Key Points
Key points are not available for this paper at this time.
Abstract
The analysis quantifies the enormity of the clinical and economic burdens of NAFLD, which will likely increase as the incidence of NAFLD continues to rise. (Hepatology 2016;64:1577-1586).